Imricor Medical Systems (IMR) Stock Price, News & Analysis

Company Overview

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 27,486 shs
• Average Volume: N/A
• Market Capitalization: A$167.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IMR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Imricor Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Imricor Medical Systems investors own include Frequency Therapeutics (FREQ), Cue Biopharma (CUE), Provention Bio (PRVB), Gold Standard Ventures (GSV), Nuwellis (CHFS), BCB Bancorp, Inc. (NJ) (BCBP) and Atomera (ATOM).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: ASX:IMR
• CIK: N/A
• Web: www.imricor.com
• Phone: 952-818-8400
• Fax: N/A
• Employees: 140
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$20.26 million
• Net Margins: -2,458.31%
• Pretax Margin: N/A
• Return on Equity: 266.83%
• Return on Assets: -124.67%

Debt

• Debt-to-Equity Ratio: -146.38
• Current Ratio: 1.46
• Quick Ratio: 4.33

Sales & Book Value

• Annual Sales: A$868.00 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 25.56
• Book Value: A($0.03) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 270,180,000
• Free Float: N/A
• Market Cap: A$167.29 million
• Optionable: Not Optionable
• Beta: 0.26